UCB’s Brivaracetam Positive in Phase III Epilepsy Study – Analyst Blog
UCB SA ( UCBJF ) announced positive top line results from a phase III study (n=768) on epilepsy candidate, brivaracetam. …read more
Shire, ArmaGen Ink Licensing Agreeement for AGT-182 – Analyst Blog
Shire ( SHPG ) recently entered into a worldwide licensing and collaboration agreement with privately held U.S. based biotechnology company, …read more
Nielsen Expands to 2 More Countries in South America – Analyst Blog
Information and measurement company, Nielsen N.V. ( NLSN ) recently announced its plans to expand its operating footprint to two …read more
Ballard Power (BLDP) Named as Supplier for Fuel Cell Bus – Analyst Blog
A global leader in fuel cell technology Ballard Power Systems, Inc. ( BLDP ) has been selected by the heavy …read more
The Stock Market Has Reached “A Permanently High Plateau” — If The Fed Does Not Mess Up Again
Last week I wrote a post criticizing Fed chair Janet Yellen for apparently becoming a ” stock picker ” . …read more
A Much Improved “Gold Standard”: The Fisher-Hetzel Standard
Anybody who follows my blog will know that I am not a great fan of the gold standard or any …read more
Will Aon Plc (AON) Surprise Earnings Estimates This Season? – Analyst Blog
Aon Plc ( AON ) is set to report second quarter 2014 earnings results on Jul 25, 2014. Last quarter, …read more
Will AmerisourceBergen (ABC) Beat This Earnings Season? – Analyst Blog
AmerisourceBergen ( ABC ) is set to report fiscal third quarter 2014 results on Jul 24, 2014. Last quarter, AmerisourceBergen …read more
Facebook (FB) Beats Q2 Earnings, Stock Soars Higher – Analyst Blog
Social media giant Facebook ( FB ) reported Q2 earnings after the bell Thursday, and as usual the company did …read more
Bank Stocks You Should Consider
Looking for a hot bank stock? The author of today’s article believes these three bank stocks are beating the odds while most others in its… Read More »Bank Stocks You Should Consider